Ashish K Aggarwal, MD
Cardiovascular Disease (Cardiology) · Encino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 19 years
- University of Southern California Keck School of Medicine, 2007
Offices
1 location · Cardiovascular Consultants Medical Group · 13 clinicians in this group
Hospitals listed: Henry Mayo Newhall Hospital · Northridge Hospital Medical Center · Providence Cedars Sinai Tarzana Medical Center · Providence Holy Cross Medical Center · Valley Presbyterian Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Aggarwal’s office at (818) 782-5041 to ask if they take your plan before you enroll.
California Medical Board record
Licence A131211 · Current
Licensed to practise in California · since 2014 · expires 2027-12-31 · University of California, Los Angeles School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Henry Mayo Newhall HospitalValencia, CAAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.42 (0.65 to 2.18) · 4,172 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.206, Oct 2024 – Sep 2025
- Northridge Hospital Medical CenterNorthridge, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.11, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.147, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Providence Cedars Sinai Tarzana Medical CenterTarzana, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.439, Oct 2024 – Sep 2025
- Providence Holy Cross Medical CenterMission Hills, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
- Valley Presbyterian HospitalVan Nuys, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.049, Oct 2024 – Sep 2025
See every measure and the patient survey for Henry Mayo Newhall Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 3 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.42 (0.65 to 2.18) · 4,172 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.206 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.37 (0.37 to 2.37) · 885 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.22 (0.84 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.82 (119.12 to 226.52) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.7 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 128 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 410 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 214 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 2,687 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,440 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 4,489 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (1.07 to 5.61) · 837 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 193 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.64 to 3.81) · 798 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.74 (0.67 to 18.81) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.72 (0.6 to 8.85) · 177 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.99 (0.5 to 3.48) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 6.2 · 66 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 2.021 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.067 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 254 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 52.4 · 118 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 21.4 · 333 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 628 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 31 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 225 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.8 to 19.1) · 246 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 302 cases | No different | Jan 2024 – Dec 2024 |
What patients said (607 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Northridge Hospital Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.11 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.147 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.13 to 2.13) · 1,012 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.78 (0.44 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.43 (96.43 to 190.42) · 88 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 457 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.4 · 384 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 315 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,091 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.44) · 6,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 6,139 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,225 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.28 to 3.34) · 1,193 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.26 (0 to 15.07) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.14 (2.11 to 10.16) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.76) · 5,578 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 139 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 1.041 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 368 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 674 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 27.2 · 214 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.2 · 563 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 23.8 · 438 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 484 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.4) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (6.8 to 13.8) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 166 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.9 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 141 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 165 cases | No different | Jan 2024 – Dec 2024 |
What patients said (621 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Providence Cedars Sinai Tarzana Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 8 the same, 0 worse of 8 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.439 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.04 to 1.89) · 1,345 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.52 to 1.12) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 144.61 (88.03 to 201.2) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 4.2 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 517 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.7 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 153 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,946 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.38) · 6,836 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,140 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.01 (0.01 to 4.01) · 1,608 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.43 (0.9 to 3.96) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.84 to 3.69) · 1,494 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.01 (1.78 to 14.24) · 690 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.73 to 8.71) · 687 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.46 to 3.39) · 382 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.3 (0 to 0.92) · 5,423 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 202 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.299 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.416 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.714 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 195 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 623 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -14 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 4.6 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 8 · 452 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 455 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 207 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 52 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 192 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 544 cases | No different | Jan 2024 – Dec 2024 |
What patients said (511 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Providence Holy Cross Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.05 to 1.9) · 1,299 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.62 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.53 (119.32 to 217.74) · 78 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 42 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 496 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 297 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 2,960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.01 to 0.42) · 5,542 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.06 to 0.45) · 5,701 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.08 (1.02 to 5.14) · 1,284 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0 to 3.05) · 343 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.92 (0.45 to 3.4) · 1,235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (4.38 to 18.11) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.75 (2.09 to 9.41) · 353 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.44) · 313 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.29 (0 to 0.91) · 4,791 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 166 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.258 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.091 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.947 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.638 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.691 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 196 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 948 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -36.2 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.1 · 626 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 10.5 · 315 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 548 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 8.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.4 (7.2 to 15) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.7 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.3 · 104 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.8 to 17.5) · 218 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (0.9 to 1.7) · 119 cases | No different | Jan 2024 – Dec 2024 |
What patients said (439 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Valley Presbyterian Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.049 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.02) · 594 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.48 to 1.25) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 156.9 (96.19 to 217.61) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 1,116 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 3,518 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,606 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.27 (0.88 to 5.65) · 646 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 217 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.04 (0.42 to 3.66) · 635 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.41 (0 to 16.47) · 226 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.87 (0.68 to 9.06) · 208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 125 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1.24) · 3,088 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.06 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.874 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.935 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 84 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 83.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 59.4 · 264 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.7 · 360 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 359 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.2 to 17) · 88 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 56 cases | No different | Jan 2024 – Dec 2024 |
What patients said (397 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 61% |
| Doctors "always" listened carefully | 66% |
| Doctors "always" treated them with courtesy and respect | 72% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$275,635
Medicare paid this office $275,635 for 610 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 215 | $39,692 | $106 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 27 | $36,345 | $1,346 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 27 | $23,286 | $431 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $20,776 | $175 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 18 | $16,013 | $801 |
See all 32 services
| Return visit (30+ min) | 215 | $39,692 | $106 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 27 | $36,345 | $1,346 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 27 | $23,286 | $431 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $20,776 | $175 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 18 | $16,013 | $801 |
| Short return visit (20+ min) | 121 | $13,339 | $77 |
| Ultrasound of both sides of head and neck blood flow | 60 | $10,741 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $9,822 | $468 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 43 | $8,964 | $191 |
| New patient visit (45+ min) | 56 | $7,534 | $135 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $7,181 | $218 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $5,970 | $103 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $5,336 | $243 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $4,753 | $149 |
| Long return visit (40+ min) | 25 | $4,445 | $153 |
| Ultrasound of leg arteries or artery grafts | 12 | $2,788 | $232 |
| New patient visit (60+ min) | 14 | $2,781 | $199 |
| Nuclear medicine study of heart muscle blood flow by pet | 27 | $2,774 | $103 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 16 | $2,747 | $172 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 136 | $1,913 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $1,848 | $56 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 22 | $1,804 | $78 |
| Ultrasound of heart blood flow, valves and chambers | 34 | $1,490 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 130 | $1,137 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 26 | $960 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $837 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $748 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 57 | $663 | $10 |
| Short return visit | 11 | $627 | $52 |
| Injection, regadenoson, 0.1 mg | 27 | $524 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 26 | $478 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 18 | $437 | $22 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 13 | More than 34% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
610 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 19% · Women 48% · Also on Medicaid 35% · Health risk score 1.86. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 59% · Diabetes 46% · Heart failure 39% · Chronic kidney disease 39% · Atrial fibrillation 38% · Depression 30% · COPD 25% · Cancer 17% · Stroke 16% · Dementia 14%.
The office billed $937,768, Medicare allowed $352,117 and paid $275,635; for 2,030 services of 79 kinds; $524 of it was for drugs given in the office and $275,111 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 610 | 2,030 | 77 | 1.86 | $937,768 | $275,635 |
| 2023 | 562 | 1,714 | 77 | 1.71 | $599,790 | $181,048 |
| 2022 | 604 | 2,052 | 77 | 1.73 | $603,153 | $188,616 |
| 2021 | 558 | 2,201 | 77 | 1.73 | $1,128,803 | $327,905 |
| 2020 | 542 | 2,161 | 76 | 2.19 | $1,259,293 | $357,522 |
| 2019 | 633 | 2,250 | 76 | 2.47 | $808,813 | $255,731 |
| 2018 | 731 | 2,492 | 77 | 2.37 | $902,780 | $271,271 |
| 2017 | 715 | 2,352 | 77 | 2.41 | $793,713 | $240,155 |
| 2016 | 647 | 1,994 | 77 | 2.69 | $557,738 | $171,924 |
| 2015 | 549 | 1,944 | 77 | 2.85 | $498,260 | $155,244 |
| 2014 | 204 | 445 | 77 | 2.25 | $154,165 | $43,549 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Return visit (30+ min) | 202 | $35,019 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 124 | $21,978 | $165 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 28 | $9,770 | $349 |
| Ultrasound of both sides of head and neck blood flow | 60 | $9,687 | $161 |
| Short return visit (20+ min) | 92 | $8,824 | $75 |
| New patient visit (45+ min) | 62 | $8,504 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $6,849 | $99 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $6,624 | $207 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,900 | $184 |
| Ultrasound of leg arteries or artery grafts | 24 | $5,278 | $220 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 35 | $4,998 | $143 |
| Injection, regadenoson, 0.1 mg | 25 | $4,753 | None |
| Ultrasound study of arm or leg veins with compression and maneuvers | 19 | $3,225 | $170 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $1,514 | $56 |
| Ultrasound of heart blood flow, valves and chambers | 32 | $1,451 | $45 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 113 | $1,419 | $12 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 28 | $1,384 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 28 | $1,373 | $49 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 14 | $1,086 | $78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 28 | $725 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 33 | $712 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 72 | $583 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $507 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $345 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $243 | $20 |
2022: 28 services
| Return visit (30+ min) | 222 | $44,398 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 122 | $22,216 | $176 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 48 | $17,281 | $360 |
| Injection, regadenoson, 0.1 mg | 43 | $8,356 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $7,571 | $165 |
| Ultrasound of both sides of head and neck blood flow | 42 | $7,497 | $179 |
| New patient visit (45+ min) | 55 | $7,337 | $133 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 36 | $7,227 | $190 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,205 | $480 |
| Ultrasound of leg arteries or artery grafts | 26 | $6,564 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $6,134 | $88 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,028 | $201 |
| Short return visit (20+ min) | 51 | $4,472 | $73 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $4,133 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $2,616 | $53 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 47 | $2,344 | $25 |
| Telephone medical discussion with physician, 21-30 minutes | 24 | $2,268 | $78 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,236 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 124 | $1,510 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 30 | $1,230 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 48 | $1,217 | $25 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $966 | $74 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 48 | $902 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 79 | $699 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $595 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | $495 | $11 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $290 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 12 | $146 | $11 |
2021: 29 services
| Return visit (30+ min) | 216 | $41,778 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 129 | $24,240 | $178 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 62 | $23,257 | $375 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 62 | $10,744 | $87 |
| Injection, regadenoson, 0.1 mg | 53 | $9,939 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,972 | $472 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $8,893 | $89 |
| Ultrasound of both sides of head and neck blood flow | 48 | $8,668 | $177 |
| Ultrasound of leg arteries or artery grafts | 32 | $8,129 | $239 |
| New patient visit (45+ min) | 57 | $8,092 | $142 |
| Telephone medical discussion with physician, 21-30 minutes | 60 | $7,995 | $103 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,336 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $7,000 | $163 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $4,799 | $209 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 25 | $4,493 | $180 |
| Short return visit (20+ min) | 36 | $3,512 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,800 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 38 | $2,633 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 117 | $1,594 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 63 | $1,564 | $25 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $1,248 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 63 | $1,194 | $19 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,134 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $739 | $23 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 11 | $682 | $62 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $538 | $10 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $259 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 22 | $173 | $7 |
| Heart rhythm recording of continous external ekg over 8-15 days | 11 | $151 | $12 |
2020: 26 services
| Return visit (30+ min) | 197 | $38,830 | $91 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 65 | $24,435 | $376 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $15,872 | $182 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 65 | $12,765 | $98 |
| Injection, regadenoson, 0.1 mg | 60 | $11,037 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,471 | $90 |
| Ultrasound of both sides of head and neck blood flow | 48 | $8,406 | $172 |
| Ultrasound of leg arteries or artery grafts | 34 | $8,160 | $240 |
| Telephone medical discussion with physician, 21-30 minutes | 52 | $7,987 | $95 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $6,755 | $199 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,648 | $170 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 28 | $5,714 | $204 |
| New patient visit (45+ min) | 43 | $5,020 | $117 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 20 | $3,409 | $170 |
| Long return visit (40+ min) | 19 | $2,361 | $124 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $2,094 | $70 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 30 | $1,750 | $56 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 65 | $1,580 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 65 | $1,276 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $1,054 | $39 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 12 | $931 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 61 | $905 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $552 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 63 | $529 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 46 | $522 | $11 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 14 | $232 | $13 |
2019: 24 services
| Return visit (30+ min) | 203 | $40,285 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $20,928 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $18,931 | $179 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $15,043 | $173 |
| Ultrasound of both sides of head and neck blood flow | 75 | $13,444 | $179 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $12,981 | $382 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $12,161 | $468 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 42 | $8,075 | $176 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $7,568 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $7,144 | $210 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 35 | $6,791 | $97 |
| Ultrasound of leg arteries or artery grafts | 24 | $6,019 | $241 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 78 | $5,503 | $64 |
| New patient visit (45+ min) | 41 | $5,180 | $126 |
| Injection, regadenoson, 0.1 mg | 27 | $4,978 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,209 | $74 |
| Ultrasound of heart blood flow, valves and chambers | 36 | $1,781 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 104 | $1,735 | $14 |
| Long return visit (40+ min) | 13 | $1,141 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $1,100 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $977 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 34 | $825 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $677 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 54 | $595 | $10 |
2018: 25 services
| Return visit (30+ min) | 206 | $42,883 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $26,919 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 108 | $19,648 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $17,782 | $181 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $14,240 | $385 |
| Ultrasound of both sides of head and neck blood flow | 65 | $11,955 | $184 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 46 | $9,225 | $196 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $7,874 | $463 |
| New patient visit (45+ min) | 56 | $7,440 | $133 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 37 | $7,063 | $95 |
| Ultrasound of leg arteries or artery grafts | 28 | $6,665 | $238 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 98 | $6,341 | $61 |
| Injection, regadenoson, 0.1 mg | 32 | $5,376 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 44 | $3,901 | $74 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $3,760 | $171 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $3,029 | $202 |
| Long return visit (40+ min) | 17 | $2,653 | $126 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 101 | $1,796 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 168 | $1,404 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 37 | $891 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $777 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $684 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $661 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $483 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $35 | $3 |
2017: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $32,990 | $88 |
| Return visit (30+ min) | 167 | $31,465 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 134 | $26,073 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $17,759 | $200 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 37 | $13,958 | $377 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 39 | $9,556 | $245 |
| Ultrasound of both sides of head and neck blood flow | 52 | $9,068 | $174 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 40 | $8,245 | $196 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 130 | $7,792 | $53 |
| New patient visit (45+ min) | 60 | $7,784 | $130 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $7,252 | $95 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,797 | $485 |
| Ultrasound of leg arteries or artery grafts | 22 | $5,225 | $238 |
| Injection, regadenoson, 0.1 mg | 28 | $4,860 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,131 | $69 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 12 | $2,088 | $174 |
| Ultrasound of heart blood flow, valves and chambers | 42 | $2,005 | $48 |
| Long return visit (40+ min) | 13 | $1,630 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 155 | $1,339 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 83 | $1,231 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 36 | $983 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $961 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 35 | $664 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $418 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $209 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $139 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $44 | $3 |
2016: 25 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 109 | $21,991 | $170 |
| Return visit (30+ min) | 113 | $21,228 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $17,454 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $12,293 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 88 | $11,727 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 30 | $11,209 | $374 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $8,320 | $489 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,845 | $212 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 129 | $7,711 | $52 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 30 | $5,725 | $95 |
| Injection, regadenoson, 0.1 mg | 28 | $4,730 | None |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 19 | $4,618 | $243 |
| New patient visit (45+ min) | 32 | $4,521 | $141 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,363 | $112 |
| Ultrasound of both sides of head and neck blood flow | 18 | $2,992 | $166 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,491 | $226 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,029 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 215 | $1,872 | $7 |
| Short return visit (20+ min) | 21 | $1,478 | $62 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 12 | $984 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 65 | $939 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $923 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 28 | $758 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $531 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $442 | $23 |
2015: 25 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 47 | $17,571 | $374 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $14,994 | $484 |
| Return visit (30+ min) | 77 | $12,652 | $87 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 47 | $12,422 | $132 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $12,212 | $197 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 109 | $11,851 | $60 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 47 | $11,085 | $205 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,801 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $8,002 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $7,350 | $49 |
| Injection, regadenoson, 0.1 mg | 33 | $5,463 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $4,958 | $89 |
| New patient visit (45+ min) | 23 | $2,951 | $128 |
| Short return visit (20+ min) | 22 | $1,327 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 45 | $1,220 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 45 | $854 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 76 | $665 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35 | $558 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $538 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $398 | $18 |
| Ultrasound of heart, follow-up | 12 | $351 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $262 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $259 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $88 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $65 | $3 |
2014: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $5,428 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 25 | $5,047 | $202 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,608 | $243 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $3,976 | $249 |
| Return visit (30+ min) | 40 | $3,953 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,108 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 46 | $2,478 | $54 |
| New patient visit (45+ min) | 15 | $2,109 | $141 |
| New patient visit (30+ min) | 11 | $1,000 | $91 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $773 | $48 |
| Short return visit (20+ min) | 11 | $687 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $373 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $276 | $15 |
Medicaid work
$1,819 in 2024
Medicaid paid $1,819 for 328 billed services this clinician did in 2024, up to 56 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 328 | $1,819 |
| 2024 | 328 | 1 | 56 | $1,819 |
| 2023 | 242 | 1 | 57 | $1,705 |
| 2022 | 280 | 1 | 64 | $2,105 |
| 2020 | 19 | 1 | 17 | $129 |
| 2019 | 236 | 1 | 62 | $1,594 |
| 2018 | 272 | 1 | 34 | $1,346 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 242 | $1,705 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 280 | $2,105 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 19 | $129 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 236 | $1,594 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 272 | $1,346 |
Drugs they prescribed that Part D paid
$527,276
Pharmacies billed $527,276 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,447) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
1,927 generic and 520 brand-name prescriptions · $527,276 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 266 | $257,951 | $970 |
| Xarelto | 82 | $90,122 | $1,099 |
| Entresto | 90 | $85,782 | $953 |
| Jardiance | 39 | $28,053 | $719 |
| Rosuvastatin | 173 | $3,499 | $20 |
See all 34 drugs
| Eliquis | 266 | $257,951 | $970 |
| Xarelto | 82 | $90,122 | $1,099 |
| Entresto | 90 | $85,782 | $953 |
| Jardiance | 39 | $28,053 | $719 |
| Rosuvastatin | 173 | $3,499 | $20 |
| Metoprolol | 158 | $2,701 | $17 |
| Atorvastatin | 182 | $1,879 | $10 |
| Bumetanide | 47 | $1,501 | $32 |
| Eplerenone | 21 | $1,486 | $71 |
| Losartan | 108 | $1,336 | $12 |
| Clopidogrel | 107 | $1,287 | $12 |
| Amiodarone | 31 | $1,166 | $38 |
| Carvedilol | 140 | $1,163 | $8 |
| Diltiazem 24hr Er (Cd) | 40 | $1,063 | $27 |
| Digoxin | 44 | $1,056 | $24 |
| Nitroglycerin | 40 | $858 | $21 |
| Prasugrel | 15 | $854 | $57 |
| Flecainide Acetate | 22 | $804 | $37 |
| Metoprolol | 82 | $746 | $9 |
| Isosorbide Mononitrate Er | 48 | $708 | $15 |
| Amlodipine Besylate | 149 | $625 | $4 |
| Hydralazine | 55 | $624 | $11 |
| Midodrine | 11 | $507 | $46 |
| Valsartan | 17 | $368 | $22 |
| Olmesartan Medoxomil | 19 | $356 | $19 |
| Pantoprazole | 12 | $356 | $30 |
| Lisinopril | 54 | $251 | $5 |
| Furosemide | 63 | $208 | $3 |
| Atenolol | 30 | $164 | $5 |
| Spironolactone | 22 | $131 | $6 |
| Benazepril | 13 | $104 | $8 |
| Triamterene-Hydrochlorothiazid | 22 | $86 | $4 |
| Olmesartan-Hydrochlorothiazide | 13 | $81 | $6 |
| Hydrochlorothiazide | 14 | $10 | $1 |
Year by year
| 2024 | 2,447 | 404 | 0% (0) | 21% | $527,276 |
| 2023 | 2,108 | 368 | 0% (0) | 19% | $431,225 |
| 2022 | 2,292 | 376 | 0% (0) | 21% | $478,443 |
| 2021 | 2,342 | 345 | None | 19% | $392,546 |
| 2020 | 1,965 | 292 | 0% (0) | 19% | $302,325 |
| 2019 | 1,921 | 275 | 0% (0) | 19% | $228,326 |
| 2018 | 1,707 | 261 | 0% (0) | 21% | $200,016 |
| 2017 | 1,455 | 254 | None | 22% | $132,413 |
| 2016 | 1,254 | 200 | 0% (0) | 20% | $78,253 |
| 2015 | 667 | 133 | None | 18% | $32,656 |
| 2014 | 90 | 47 | 0% (0) | 14% | $2,967 |
| 2013 | 11 | None | 0% (0) | 0% | $412 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Eliquis | 216 | $220,807 | $1,022 |
| Entresto | 55 | $62,541 | $1,137 |
| Xarelto | 44 | $51,781 | $1,177 |
| Brilinta | 13 | $13,568 | $1,044 |
| Repatha Sureclick | 12 | $12,565 | $1,047 |
| Rosuvastatin | 180 | $6,760 | $38 |
| Metoprolol | 191 | $5,361 | $28 |
| Atorvastatin | 165 | $2,635 | $16 |
| Ezetimibe | 30 | $2,216 | $74 |
| Losartan | 110 | $2,130 | $19 |
| Eplerenone | 13 | $2,031 | $156 |
| Carvedilol | 133 | $1,823 | $14 |
| Isosorbide Mononitrate Er | 54 | $1,552 | $29 |
| Digoxin | 37 | $1,495 | $40 |
| Amiodarone | 21 | $1,295 | $62 |
| Amlodipine Besylate | 118 | $1,199 | $10 |
| Metoprolol | 71 | $976 | $14 |
| Nitroglycerin | 31 | $937 | $30 |
| Valsartan | 22 | $935 | $42 |
| Olmesartan Medoxomil | 18 | $807 | $45 |
| Hydralazine | 26 | $792 | $30 |
| Clopidogrel | 68 | $783 | $12 |
| Niacin Er | 13 | $755 | $58 |
| Diltiazem 24hr Er (Cd) | 29 | $745 | $26 |
| Flecainide Acetate | 11 | $717 | $65 |
| Lisinopril | 55 | $713 | $13 |
| Bumetanide | 21 | $650 | $31 |
| Chlorthalidone | 21 | $549 | $26 |
| Furosemide | 57 | $509 | $9 |
| Spironolactone | 22 | $265 | $12 |
| Pantoprazole | 19 | $256 | $13 |
| Benazepril | 21 | $202 | $10 |
| Atenolol | 16 | $183 | $11 |
| Lovastatin | 12 | $163 | $14 |
| Gemfibrozil | 17 | $149 | $9 |
2022: 36 drugs
| Eliquis | 185 | $191,167 | $1,033 |
| Xarelto | 79 | $87,099 | $1,103 |
| Entresto | 78 | $81,082 | $1,040 |
| Brilinta | 28 | $17,314 | $618 |
| Repatha Sureclick | 20 | $10,899 | $545 |
| Rosuvastatin | 149 | $8,667 | $58 |
| Vascepa | 11 | $4,971 | $452 |
| Eplerenone | 31 | $4,578 | $148 |
| Metoprolol | 165 | $4,221 | $26 |
| Ezetimibe | 33 | $2,949 | $89 |
| Atorvastatin | 189 | $2,614 | $14 |
| Bumetanide | 23 | $2,456 | $107 |
| Carvedilol | 155 | $2,097 | $14 |
| Amiodarone | 38 | $2,023 | $53 |
| Cozaar | 12 | $1,992 | $166 |
| Digoxin | 47 | $1,978 | $42 |
| Losartan | 85 | $1,588 | $19 |
| Clopidogrel | 84 | $1,376 | $16 |
| Nitroglycerin | 30 | $1,289 | $43 |
| Isosorbide Mononitrate Er | 53 | $1,176 | $22 |
| Amlodipine Besylate | 114 | $1,166 | $10 |
| Lisinopril | 84 | $829 | $10 |
| Pantoprazole | 29 | $716 | $25 |
| Diltiazem 24hr Er (Cd) | 22 | $709 | $32 |
| Spironolactone | 48 | $650 | $14 |
| Hydralazine | 24 | $644 | $27 |
| Furosemide | 78 | $599 | $8 |
| Olmesartan Medoxomil | 17 | $575 | $34 |
| Chlorthalidone | 17 | $490 | $29 |
| Metoprolol | 59 | $488 | $8 |
| Potassium Chloride | 12 | $325 | $27 |
| Benazepril | 22 | $227 | $10 |
| Pravastatin | 14 | $225 | $16 |
| Hydrochlorothiazide | 17 | $219 | $13 |
| Atenolol | 16 | $97 | $6 |
| Clonidine | 12 | $30 | $3 |
2021: 33 drugs
| Eliquis | 175 | $166,943 | $954 |
| Xarelto | 62 | $68,626 | $1,107 |
| Entresto | 51 | $54,220 | $1,063 |
| Brilinta | 32 | $18,270 | $571 |
| Rosuvastatin | 131 | $5,557 | $42 |
| Eplerenone | 54 | $5,528 | $102 |
| Metoprolol | 153 | $4,358 | $28 |
| Atorvastatin | 221 | $3,004 | $14 |
| Digoxin | 63 | $2,750 | $44 |
| Amiodarone | 38 | $2,484 | $65 |
| Cozaar | 12 | $1,919 | $160 |
| Carvedilol | 161 | $1,793 | $11 |
| Isosorbide Mononitrate Er | 67 | $1,683 | $25 |
| Prasugrel | 18 | $1,681 | $93 |
| Losartan | 84 | $1,462 | $17 |
| Diltiazem 24hr Er (Cd) | 24 | $1,385 | $58 |
| Nitroglycerin | 32 | $1,330 | $42 |
| Bumetanide | 25 | $1,253 | $50 |
| Amlodipine Besylate | 138 | $1,168 | $8 |
| Furosemide | 103 | $889 | $9 |
| Clopidogrel | 78 | $855 | $11 |
| Lisinopril | 95 | $829 | $9 |
| Verapamil Er | 17 | $773 | $45 |
| Ezetimibe | 13 | $679 | $52 |
| Pantoprazole | 32 | $633 | $20 |
| Metoprolol | 79 | $594 | $8 |
| Pravastatin | 36 | $565 | $16 |
| Spironolactone | 36 | $519 | $14 |
| Potassium Chloride | 14 | $379 | $27 |
| Hydralazine | 11 | $344 | $31 |
| Benazepril | 28 | $275 | $10 |
| Omeprazole | 14 | $217 | $15 |
| Triamterene-Hydrochlorothiazid | 12 | $124 | $10 |
2020: 26 drugs
| Eliquis | 182 | $147,808 | $812 |
| Xarelto | 40 | $41,760 | $1,044 |
| Entresto | 34 | $28,416 | $836 |
| Brilinta | 15 | $15,050 | $1,003 |
| Rosuvastatin | 98 | $5,355 | $55 |
| Eplerenone | 47 | $5,291 | $113 |
| Metoprolol | 165 | $4,500 | $27 |
| Atorvastatin | 148 | $2,524 | $17 |
| Digoxin | 55 | $2,016 | $37 |
| Amiodarone | 31 | $1,842 | $59 |
| Isosorbide Mononitrate Er | 66 | $1,697 | $26 |
| Amlodipine Besylate | 151 | $1,682 | $11 |
| Carvedilol | 140 | $1,513 | $11 |
| Nitroglycerin | 40 | $1,285 | $32 |
| Clopidogrel | 90 | $1,242 | $14 |
| Losartan | 66 | $924 | $14 |
| Pravastatin | 43 | $915 | $21 |
| Lisinopril | 107 | $826 | $8 |
| Furosemide | 79 | $665 | $8 |
| Pantoprazole | 24 | $599 | $25 |
| Flecainide Acetate | 15 | $562 | $37 |
| Metoprolol | 51 | $448 | $9 |
| Diltiazem 24hr Er (Cd) | 11 | $387 | $35 |
| Spironolactone | 37 | $331 | $9 |
| Hydralazine | 11 | $215 | $20 |
| Benazepril | 18 | $158 | $9 |
2019: 29 drugs
| Eliquis | 146 | $88,876 | $609 |
| Xarelto | 37 | $37,020 | $1,001 |
| Entresto | 33 | $20,683 | $627 |
| Multaq | 11 | $12,954 | $1,178 |
| Metoprolol | 195 | $5,571 | $29 |
| Eplerenone | 43 | $5,202 | $121 |
| Rosuvastatin | 56 | $4,123 | $74 |
| Atorvastatin | 134 | $2,945 | $22 |
| Toprol Xl | 17 | $1,937 | $114 |
| Clopidogrel | 139 | $1,909 | $14 |
| Digoxin | 49 | $1,898 | $39 |
| Isosorbide Mononitrate Er | 71 | $1,802 | $25 |
| Carvedilol | 136 | $1,582 | $12 |
| Amlodipine Besylate | 127 | $1,290 | $10 |
| Amiodarone | 35 | $1,193 | $34 |
| Losartan | 66 | $1,151 | $17 |
| Nitroglycerin | 34 | $1,127 | $33 |
| Pravastatin | 56 | $1,031 | $18 |
| Cartia Xt | 11 | $730 | $66 |
| Lisinopril | 94 | $699 | $7 |
| Digox | 12 | $551 | $46 |
| Furosemide | 82 | $522 | $6 |
| Metoprolol | 59 | $466 | $8 |
| Spironolactone | 36 | $357 | $10 |
| Hydralazine | 14 | $343 | $25 |
| Ramipril | 11 | $191 | $17 |
| Omeprazole | 15 | $171 | $11 |
| Lovastatin | 17 | $98 | $6 |
| Atenolol | 13 | $89 | $7 |
2018: 28 drugs
| Eliquis | 132 | $76,866 | $582 |
| Xarelto | 43 | $38,619 | $898 |
| Multaq | 15 | $13,786 | $919 |
| Ranexa | 14 | $9,300 | $664 |
| Metoprolol | 132 | $4,362 | $33 |
| Eplerenone | 23 | $2,555 | $111 |
| Atorvastatin | 126 | $2,199 | $17 |
| Amiodarone | 35 | $2,154 | $62 |
| Isosorbide Mononitrate Er | 87 | $1,881 | $22 |
| Clopidogrel | 117 | $1,540 | $13 |
| Nitroglycerin | 38 | $1,452 | $38 |
| Carvedilol | 134 | $1,339 | $10 |
| Toprol Xl | 17 | $1,307 | $77 |
| Valsartan | 13 | $1,197 | $92 |
| Amlodipine Besylate | 122 | $1,195 | $10 |
| Rosuvastatin | 24 | $1,081 | $45 |
| Pravastatin | 44 | $999 | $23 |
| Bumetanide | 17 | $899 | $53 |
| Losartan | 68 | $778 | $11 |
| Metoprolol | 81 | $636 | $8 |
| Hydralazine | 32 | $595 | $19 |
| Digox | 11 | $480 | $44 |
| Cartia Xt | 11 | $454 | $41 |
| Spironolactone | 51 | $427 | $8 |
| Furosemide | 71 | $342 | $5 |
| Lisinopril | 53 | $249 | $5 |
| Benazepril | 13 | $131 | $10 |
| Omeprazole | 19 | $103 | $5 |
2017: 25 drugs
| Eliquis | 90 | $49,157 | $546 |
| Xarelto | 35 | $26,317 | $752 |
| Ranexa | 16 | $6,893 | $431 |
| Entresto | 11 | $6,327 | $575 |
| Metoprolol | 136 | $4,845 | $36 |
| Atorvastatin | 137 | $2,909 | $21 |
| Eplerenone | 14 | $1,922 | $137 |
| Pravastatin | 52 | $1,873 | $36 |
| Isosorbide Mononitrate Er | 78 | $1,806 | $23 |
| Valsartan | 27 | $1,683 | $62 |
| Carvedilol | 117 | $1,146 | $10 |
| Clopidogrel | 74 | $1,041 | $14 |
| Chlorthalidone | 23 | $958 | $42 |
| Amiodarone | 23 | $894 | $39 |
| Losartan | 55 | $807 | $15 |
| Nitroglycerin | 26 | $795 | $31 |
| Amlodipine Besylate | 80 | $591 | $7 |
| Metoprolol | 65 | $529 | $8 |
| Lisinopril | 85 | $393 | $5 |
| Spironolactone | 38 | $283 | $7 |
| Diltiazem 24hr Er | 12 | $256 | $21 |
| Hydralazine | 11 | $249 | $23 |
| Benazepril | 18 | $228 | $13 |
| Omeprazole | 22 | $171 | $8 |
| Furosemide | 46 | $167 | $4 |
2016: 26 drugs
| Eliquis | 46 | $19,994 | $435 |
| Xarelto | 34 | $17,586 | $517 |
| Effient | 11 | $4,157 | $378 |
| Metoprolol | 117 | $3,478 | $30 |
| Crestor | 11 | $3,080 | $280 |
| Atorvastatin | 144 | $2,913 | $20 |
| Pravastatin | 51 | $1,661 | $33 |
| Isosorbide Mononitrate Er | 57 | $1,354 | $24 |
| Amiodarone | 17 | $1,079 | $63 |
| Carvedilol | 98 | $868 | $9 |
| Clopidogrel | 43 | $867 | $20 |
| Digoxin | 16 | $772 | $48 |
| Losartan | 54 | $698 | $13 |
| Chlorthalidone | 15 | $688 | $46 |
| Metoprolol | 67 | $565 | $8 |
| Nitrostat | 19 | $563 | $30 |
| Amlodipine Besylate | 53 | $530 | $10 |
| Verapamil Er | 21 | $485 | $23 |
| Valsartan | 15 | $409 | $27 |
| Spironolactone | 50 | $370 | $7 |
| Lisinopril | 47 | $316 | $7 |
| Hydralazine | 11 | $281 | $26 |
| Benazepril | 41 | $267 | $7 |
| Furosemide | 28 | $145 | $5 |
| Omeprazole | 13 | $90 | $7 |
| Simvastatin | 13 | $54 | $4 |
2015: 19 drugs
| Eliquis | 15 | $5,791 | $386 |
| Crestor | 13 | $3,761 | $289 |
| Atorvastatin | 59 | $1,253 | $21 |
| Metoprolol | 46 | $1,109 | $24 |
| Pravastatin | 44 | $961 | $22 |
| Isosorbide Mononitrate Er | 34 | $652 | $19 |
| Carvedilol | 51 | $592 | $12 |
| Clopidogrel | 38 | $485 | $13 |
| Metoprolol | 40 | $339 | $8 |
| Amlodipine Besylate | 34 | $300 | $9 |
| Nitrostat | 15 | $273 | $18 |
| Cartia Xt | 12 | $258 | $22 |
| Losartan | 25 | $218 | $9 |
| Atenolol | 22 | $203 | $9 |
| Hydralazine | 12 | $198 | $17 |
| Benazepril | 21 | $149 | $7 |
| Spironolactone | 17 | $114 | $7 |
| Lisinopril | 12 | $76 | $6 |
| Furosemide | 15 | $68 | $5 |
2014: 2 drugs
| Clopidogrel | 14 | $329 | $23 |
| Isosorbide Mononitrate Er | 12 | $116 | $10 |
Money from drug and device companies
$598 in 2025
| 2025 | 8 | 17 | None | $598 |
| 2024 | 8 | 12 | None | $424 |
| 2023 | 5 | 18 | None | $454 |
| 2022 | 4 | 12 | None | $512 |
| 2021 | 5 | 7 | None | $244 |
| 2020 | 2 | 10 | None | $641 |
| 2019 | 6 | 11 | None | $426 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Aveir | $351 | 9 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $68 | 1 payment
|
| Abiomed | None | $40 | 1 payment
|
| Heartflow | Ffrct | $39 | 2 payments
|
| Amgen | Repatha | $32 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 1 payment
|
See all 17 published payments
| Abbott Laboratories | Meals · 2025-12-10 | Jot Dx | $24 |
| Abbott Laboratories | Meals · 2025-10-31 | Gallant | $52 |
| Heartflow | Meals · 2025-10-29 | Ffrct | $22 |
| Abbott Laboratories | Meals · 2025-09-15 | Jot Dx | $11 |
| Abbott Laboratories | Meals · 2025-08-18 | Aveir | $138 |
| Abbott Laboratories | Meals · 2025-08-15 | Pressurewire | $18 |
| Abbott Laboratories | Meals · 2025-08-15 | Pressurewire | $1 |
| Shockwave Medical | Meals · 2025-07-30 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $68 |
| Abbott Laboratories | Meals · 2025-07-25 | Jot Dx | $13 |
| Heartflow | Meals · 2025-07-16 | Ffrct | $18 |
| Abbott Laboratories | Meals · 2025-07-07 | Aveir | $70 |
| Amgen | Meals · 2025-05-15 | Repatha | $32 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-07 | Lifevest | $32 |
| Abiomed | Meals · 2025-04-15 | None | $40 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-27 | Eliquis | $18 |
| Abbott Laboratories | Meals · 2025-01-14 | Merlin@Home | $23 |
| Medtronic | Meals · 2025-01-13 | Selectsecure | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $424
| Abbott Laboratories | Jot Dx | $250 | 5 payments
|
| Biosense Webster | Carto 3 | $32 | 1 payment
|
| Pfizer | Vyndaqel | $31 | 1 payment
|
| Boston Scientific | Mamba | $31 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $25 | 1 payment
|
| iRhythm Technologies | Zio Monitor | $20 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $16 | 1 payment
|
2023: $454
| Abbott Laboratories | Jot Dx | $357 | 13 payments
|
| Boston Scientific | Wolverine Coronary Cutting Balloon | $37 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $17 | 1 payment
|
2022: $512
| Abbott Laboratories | Confirm Rx | $444 | 8 payments
|
| Itamar Medical | Watchpat | $32 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $14 | 1 payment
|
2021: $244
| Abbott Laboratories | Confirm Rx | $162 | 3 payments
|
| Pfizer | Eliquis | $34 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $16 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $14 | 1 payment
|
2020: $641
| Abbott Laboratories | Fortify Assura, Ellipse Icd | $605 | 8 payments
|
| Novartis Pharmaceuticals | Entresto | $37 | 2 payments
|
2019: $426
| Abbott Laboratories | Fortify Assura, Ellipse Icd | $307 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $36 | 2 payments
|
| Amgen | Corlanor | $34 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $14 | 1 payment
|
| CathWorks | Ffrangio System | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760682868
- Licence
- CA A131211California A131211: Current · expires 2027-12-31
- Trained
- University of Southern California Keck School of Medicine, 2007 · 19 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 16542 Ventura Blvd Ste 402, Encino, CA, 91436
- NPI first listed
- 2007-07-18
- NPI last updated
- 2022-08-12
- NPI record certified
- 2022-08-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 23929 Mcbean Pkwy Ste 216, Valencia, CA, 91355
This office lists an electronic records connection.